T. C. Merigan

4.7k total citations · 1 hit paper
89 papers, 3.7k citations indexed

About

T. C. Merigan is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, T. C. Merigan has authored 89 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 26 papers in Infectious Diseases and 22 papers in Virology. Recurrent topics in T. C. Merigan's work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (19 papers) and Herpesvirus Infections and Treatments (12 papers). T. C. Merigan is often cited by papers focused on HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (19 papers) and Herpesvirus Infections and Treatments (12 papers). T. C. Merigan collaborates with scholars based in United States, United Kingdom and France. T. C. Merigan's co-authors include Teresa Y. Basham, Mark A. Winters, David Katzenstein, Lucy Rasmussen, Mark Holodniy, Robert W. Shafer, John W. Torseth, Adriana Weinberg, Astrid K. N. Iversen and Marie‐Françoise Bourgeade and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

T. C. Merigan

89 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recombinant interferon-gamma increases HLA-DR synthesis and expression.

1983 504 citations Teresa Y. Basham, T. C. Merigan The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. C. Merigan United States	35	1.2k	1.1k	1.0k	952	508	89	3.7k
F. Dianzani Italy	38	1.7k 1.4×	1.2k 1.0×	901 0.9×	1.0k 1.1×	590 1.2×	187	4.2k
JE Groopman United States	34	1.5k 1.2×	755 0.7×	967 0.9×	1.6k 1.6×	793 1.6×	55	4.5k
Paul M. Feorino United States	25	813 0.7×	1.3k 1.1×	1.4k 1.4×	1.3k 1.4×	888 1.7×	61	3.7k
T. C. Merigan United States	45	1.5k 1.2×	2.5k 2.2×	1.7k 1.7×	1.8k 1.9×	520 1.0×	128	5.6k
Jean‐Marie Andrieu France	28	953 0.8×	511 0.4×	586 0.6×	1.2k 1.2×	566 1.1×	89	2.8k
M. S. Hirsch United States	27	1.1k 0.9×	1.6k 1.4×	1.1k 1.1×	1.2k 1.2×	500 1.0×	42	3.3k
Janet K.A. Nicholson United States	30	2.1k 1.7×	990 0.9×	1.4k 1.3×	2.6k 2.8×	203 0.4×	72	4.3k
Heribert Stoiber Austria	36	2.0k 1.6×	921 0.8×	894 0.9×	1.6k 1.7×	496 1.0×	119	3.6k
P D Markham United States	24	944 0.8×	1.1k 1.0×	1.0k 1.0×	1.5k 1.6×	614 1.2×	35	3.0k
John Hackett United States	29	1.4k 1.1×	407 0.4×	783 0.8×	686 0.7×	327 0.6×	75	2.9k

Countries citing papers authored by T. C. Merigan

Since Specialization

Citations

This map shows the geographic impact of T. C. Merigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. C. Merigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. C. Merigan more than expected).

Fields of papers citing papers by T. C. Merigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. C. Merigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. C. Merigan. The network helps show where T. C. Merigan may publish in the future.

Co-authorship network of co-authors of T. C. Merigan

This figure shows the co-authorship network connecting the top 25 collaborators of T. C. Merigan. A scholar is included among the top collaborators of T. C. Merigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. C. Merigan. T. C. Merigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawrence, Jody, Jonathan Schapiro, Mark A. Winters, et al.. (1999). Clinical Resistance Patterns and Responses to Two Sequential Protease Inhibitor Regimens in Saquinavir and Reverse Transcriptase Inhibitor–Experienced Persons. The Journal of Infectious Diseases. 179(6). 1356–1364. 51 indexed citations

Karp, Barbara, et al.. (1996). Multiple cerebral lesions complicating therapy with interleukin-2. Neurology. 47(2). 417–424. 34 indexed citations

Rasmussen, Lucy, Shannon R. Morris, Donato Zipeto, et al.. (1995). Quantitation of Human Cytomegalovirus DNA from Peripheral Blood Cells of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis. Retina. 15(4). 362–362. 1 indexed citations

Arezzo, Joseph C., Herbert H. Schaumburg, Gail Skowron, et al.. (1993). 2',3'‐Dideoxycytidine (ddC) toxic neuropathy. Neurology. 43(2). 358–358. 110 indexed citations

Hamed, Kamal, Mark A. Winters, Mark Holodniy, David Katzenstein, & T. C. Merigan. (1993). Detection of Human Immunodeficiency Virus Type 1 in Semen: Effects of Disease Stage and Nucleoside Therapy. The Journal of Infectious Diseases. 167(4). 798–802. 74 indexed citations

Holodniy, Mark, David Katzenstein, Dennis Israelski, & T. C. Merigan. (1991). Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.. Journal of Clinical Investigation. 88(5). 1755–1759. 68 indexed citations

Volberding, Paul, Stephen W. Lagakos, C B Pettinelli, et al.. (1990). Safety and Efficacy of zidovudine in asymptomatic HIV infected individuals withless than 500 CD4+ cells/mm3.. 941–949. 5 indexed citations

Merigan, T. C.. (1990). YouCanTeach an Old Dog New Tricks. New England Journal of Medicine. 323(19). 1341–1343. 30 indexed citations

Miller, RA, SJ Horning, Teresa Y. Basham, et al.. (1989). Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood. 73(3). 651–661. 6 indexed citations

10.

Weinberg, Adriana & T. C. Merigan. (1988). Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.. The Journal of Immunology. 140(1). 294–299. 90 indexed citations

11.

Bissett, Jack, et al.. (1988). Recombinant Fibroblast Interferon and Immune Interferon for Treating Chronic Hepatitis B Virus Infection: Patients' Tolerance and the Effect on Viral Markers. The Journal of Infectious Diseases. 157(5). 1076–1080. 21 indexed citations

12.

Keay, S., Jack Bissett, & T. C. Merigan. (1987). Ganciclovir Treatment of Cytomegalovirus Infections in Iatrogenically Immunocompromised Patients. The Journal of Infectious Diseases. 156(6). 1016–1021. 29 indexed citations

13.

Seto, WH, et al.. (1984). Exfoliative cytology in the evaluation of interferon treatment of cervical intraepithelial neoplasia.. PubMed. 28(2). 111–7. 7 indexed citations

14.

Härfast, Bengt, John Huddlestone, Paolo Casali, T. C. Merigan, & M B Oldstone. (1981). Interferon acts directly on human B lymphocytes to modulate immunoglobulin synthesis.. The Journal of Immunology. 127(5). 2146–2150. 85 indexed citations

15.

Scullard, G, et al.. (1979). The effect of immuno suppressive therapy on hepatitis b viral infection in patients with chronic hepatitis. Gastroenterology. 77(5). 40. 10 indexed citations

16.

Denman, A. M., Bracha Rager‐Zisman, T. C. Merigan, & D. A. J. Tyrrell. (1974). Replication or Inactivation of Different Viruses by Human Lymphocyte Preparations. Infection and Immunity. 9(2). 373–376. 23 indexed citations

17.

Rager‐Zisman, Bracha & T. C. Merigan. (1973). A Useful Quantitative Semimicromethod for Viral Plaque Assay. Experimental Biology and Medicine. 142(4). 1174–1179. 36 indexed citations

18.

Armstrong, Robert W. & T. C. Merigan. (1971). Varicella Zoster Virus: Interferon Production and Comparative Interferon Sensitivity in Human Cell Cultures. Journal of General Virology. 12(1). 53–54. 18 indexed citations

19.

Finkelstein, Martin S. & T. C. Merigan. (1968). Interferon--1968. How much do we understand?. PubMed. 109(1). 24–34. 4 indexed citations

20.

Merigan, T. C. & W. J. Kleinschmidt. (1965). Different Molecular Species of Mouse Interferon Induced by Statolon. Nature. 208(5011). 667–669. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact